AttgeNO

About:

AttgeNO is a pharmaceutical company developing treatments for acute life-threatening conditions.

Website: https://attgeno.com/

Top Investors: Hadean Ventures

Description:

AttgeNO is a pharmaceutical company developing treatments for acute life-threatening conditions.

Total Funding Amount:

30M SEK

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Stockholm, Stockholms Lan, Sweden

Founded Date:

2005-01-01

Founders:

Christofer Adding, Per Agvald

Number of Employees:

1-10

Last Funding Date:

2018-05-22

IPO Status:

Private

Industries: